Off-market insider buying at Diagnos (ADK)

Off-market insider buying at Diagnos (V:ADK)

Tristram Coffin, a 10% Holder, acquired 700,000 Common Shares on an indirect ownership basis for registered holder 9071-8776 Quebec Inc. at a price of $0.280 through a prospectus or prospectus exempt offering on February 27th, 2024. The insider also acquired 700,000 Warrants with an exercise price of $0.400 for 18 months. This represents a $196,000 investment into the company's shares and an account share holdings change of 9.6%.

Diagnos is in the IT Services & Consulting Sub Industry Group under the Technology Sector.

DIAGNOS Inc. is a Canadian company, which is engaged in early detection of critical health problems based on its FLAIRE artificial intelligence (AI) platform. FLAIRE allows for modifying and developing of applications, such as Computer Assisted Retina Analysis (CARA). CARA's image enhancement algorithms provide sharper, clearer and easier-to-analyze retinal images. CARA is a tool for real-time screening of large volumes of patients. Its geographical areas include Canada, the United States, Saudi Arabia, Mexico, Costa Rica and Chile. The Company's subsidiaries include Diagnos Internacional SA de CV and Diagnos Healthcare (India) Private Limited.